STOCK TITAN

[Form 4] Sachem Capital Corp. 7.75% Notes due 2025 Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Jeffery C. Walraven, identified as Executive Vice President and Chief Financial Officer, reported a purchase of 236,220 common shares of Sachem Capital Corp. on 09/03/2025. The transaction is recorded as an acquisition with a price shown as $0 (not applicable per the filing). After the reported transaction Mr. Walraven beneficially owned 256,220 shares in a direct ownership form. The filing is a Form 4 statement of changes in beneficial ownership signed by the reporting person on 09/05/2025.

Jeffery C. Walraven, indicato come Executive Vice President e Chief Financial Officer, ha dichiarato l'acquisto di 236.220 azioni ordinarie di Sachem Capital Corp. in data 09/03/2025. La transazione è riportata come acquisizione con prezzo indicato $0 (non applicabile secondo il deposito). Dopo l'operazione, il Sig. Walraven deteneva beneficiariamente 256.220 azioni in proprietà diretta. Il documento è un Modulo 4 relativo alle variazioni nella proprietà beneficiaria, firmato dalla persona che ha effettuato la comunicazione in data 09/05/2025.

Jeffery C. Walraven, identificado como Executive Vice President y Chief Financial Officer, informó la compra de 236.220 acciones comunes de Sachem Capital Corp. el 09/03/2025. La operación se registra como una adquisición con precio mostrado $0 (no aplicable según la presentación). Tras la transacción informada, el Sr. Walraven poseía beneficiariamente 256.220 acciones en forma de propiedad directa. La declaración corresponde a un Formulario 4 sobre cambios en la propiedad beneficiaria, firmado por el informante el 09/05/2025.

Jeffery C. Walraven는 Executive Vice President 겸 Chief Financial Officer로 확인되며, 2025-09-03에 Sachem Capital Corp.의 보통주 236,220주를 매수했다고 보고했습니다. 해당 거래는 인수로 기재되며 서류상 가격은 $0로 표기되어 있습니다(신고서상 해당 없음). 보고된 거래 후 Walraven 씨는 직접 소유 형태로 256,220주의 실질적 소유권을 보유하고 있었습니다. 이 신고는 유효 소유권 변동을 알리는 Form 4로, 보고인이 2025-09-05에 서명했습니다.

Jeffery C. Walraven, identifié comme Executive Vice President et Chief Financial Officer, a déclaré l'achat de 236 220 actions ordinaires de Sachem Capital Corp. le 09/03/2025. La transaction est enregistrée comme une acquisition avec un prix indiqué de $0 (non applicable d'après le dépôt). Après la transaction déclarée, M. Walraven détenait à titre bénéficiaire 256 220 actions en propriété directe. Le dépôt constitue un formulaire 4 relatif aux changements de propriété bénéficiaire, signé par le déclarant le 09/05/2025.

Jeffery C. Walraven, ausgewiesen als Executive Vice President und Chief Financial Officer, meldete den Kauf von 236.220 Stammaktien der Sachem Capital Corp. am 09/03/2025. Die Transaktion ist als Erwerb aufgeführt, der Preis wird mit $0 angegeben (laut Einreichung nicht anwendbar). Nach der gemeldeten Transaktion besaß Herr Walraven wirtschaftlich 256.220 Aktien in Form von direktem Eigentum. Die Einreichung ist eine Form 4-Erklärung über Änderungen der wirtschaftlichen Eigentumsverhältnisse, unterschrieben vom Melder am 09/05/2025.

Positive
  • Significant insider purchase disclosed: 236,220 common shares acquired, increasing the CFO's direct holdings to 256,220 shares.
  • Timely compliance: Form 4 was signed and filed, providing required transparency about insider ownership changes.
Negative
  • None.

Insights

TL;DR Insider acquisition of 236,220 shares by the CFO increases direct stake to 256,220 shares, a potentially supportive signal to investors.

The Form 4 discloses a sizable non-derivative acquisition executed on 09/03/2025 that raised the reporting person's direct holdings. The filing lists the transaction price as $0 with an explanatory note of not applicable; the absence of a cash price in the filing limits interpretation of economic terms. From a capital-structure perspective, this increases insider-aligned ownership but the filing does not state percentage ownership or relation to outstanding shares, which constrains assessment of scale.

TL;DR A senior officer disclosed a direct purchase increasing his holdings, which is a governance-affirming disclosure but lacks pricing context.

The report is timely and properly executed as a Form 4, signed on 09/05/2025, and shows direct beneficial ownership following the transaction. The documentation meets Section 16 reporting requirements by identifying role (EVP and CFO) and the exact share counts. However, the filing omits a monetary price (marked $0 with note), so stakeholders cannot determine whether the shares were purchased, issued, awarded, or transferred under another arrangement from this form alone.

Jeffery C. Walraven, indicato come Executive Vice President e Chief Financial Officer, ha dichiarato l'acquisto di 236.220 azioni ordinarie di Sachem Capital Corp. in data 09/03/2025. La transazione è riportata come acquisizione con prezzo indicato $0 (non applicabile secondo il deposito). Dopo l'operazione, il Sig. Walraven deteneva beneficiariamente 256.220 azioni in proprietà diretta. Il documento è un Modulo 4 relativo alle variazioni nella proprietà beneficiaria, firmato dalla persona che ha effettuato la comunicazione in data 09/05/2025.

Jeffery C. Walraven, identificado como Executive Vice President y Chief Financial Officer, informó la compra de 236.220 acciones comunes de Sachem Capital Corp. el 09/03/2025. La operación se registra como una adquisición con precio mostrado $0 (no aplicable según la presentación). Tras la transacción informada, el Sr. Walraven poseía beneficiariamente 256.220 acciones en forma de propiedad directa. La declaración corresponde a un Formulario 4 sobre cambios en la propiedad beneficiaria, firmado por el informante el 09/05/2025.

Jeffery C. Walraven는 Executive Vice President 겸 Chief Financial Officer로 확인되며, 2025-09-03에 Sachem Capital Corp.의 보통주 236,220주를 매수했다고 보고했습니다. 해당 거래는 인수로 기재되며 서류상 가격은 $0로 표기되어 있습니다(신고서상 해당 없음). 보고된 거래 후 Walraven 씨는 직접 소유 형태로 256,220주의 실질적 소유권을 보유하고 있었습니다. 이 신고는 유효 소유권 변동을 알리는 Form 4로, 보고인이 2025-09-05에 서명했습니다.

Jeffery C. Walraven, identifié comme Executive Vice President et Chief Financial Officer, a déclaré l'achat de 236 220 actions ordinaires de Sachem Capital Corp. le 09/03/2025. La transaction est enregistrée comme une acquisition avec un prix indiqué de $0 (non applicable d'après le dépôt). Après la transaction déclarée, M. Walraven détenait à titre bénéficiaire 256 220 actions en propriété directe. Le dépôt constitue un formulaire 4 relatif aux changements de propriété bénéficiaire, signé par le déclarant le 09/05/2025.

Jeffery C. Walraven, ausgewiesen als Executive Vice President und Chief Financial Officer, meldete den Kauf von 236.220 Stammaktien der Sachem Capital Corp. am 09/03/2025. Die Transaktion ist als Erwerb aufgeführt, der Preis wird mit $0 angegeben (laut Einreichung nicht anwendbar). Nach der gemeldeten Transaktion besaß Herr Walraven wirtschaftlich 256.220 Aktien in Form von direktem Eigentum. Die Einreichung ist eine Form 4-Erklärung über Änderungen der wirtschaftlichen Eigentumsverhältnisse, unterschrieben vom Melder am 09/05/2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Walraven Jeffery C

(Last) (First) (Middle)
C/O 568 EAST MAIN STREET

(Street)
BRANFORD CT 06405

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sachem Capital Corp. [ SACH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and CFO
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, par value $0.001 per share 09/03/2025 A 236,220 A $0(1) 256,220 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Not applicable.
Remarks:
/s/ Jeffery C. Walraven 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed by Jeffery C. Walraven report?

The filing reports that Jeffery C. Walraven, EVP and CFO, acquired 236,220 common shares of Sachem Capital Corp. on 09/03/2025, bringing his direct holdings to 256,220 shares.

What price was reported for the shares purchased on the Form 4?

The filing lists the price as $0 with a note stating not applicable, so the Form 4 does not provide a cash purchase price.

When was the Form 4 signed by the reporting person?

The Form 4 bears the reporting person's signature dated 09/05/2025.

Does the Form 4 show indirect ownership or derivative transactions?

No. The filing shows direct ownership for the common shares and contains no entries in the derivatives section.

What role does the reporting person hold at the issuer?

The Form 4 identifies the reporting person as an Executive Vice President and Chief Financial Officer of Sachem Capital Corp.
Sachem Cap Corp

NYSE:SCCC

SCCC Rankings

SCCC Latest SEC Filings

SCCC Stock Data

520.00k
Savings Institutions
Real Estate Investment Trusts
Link
BRANFORD